This inventor holds 1 USPTO granted patent. Top assignee: Humboldt-Universitaet Zu Berlin. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Joerg Beger: Innovator in Pharmaceutical Chemistry
Introduction
Joerg Beger is a notable inventor based in Freiberg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new compounds.
Latest Patents
Beger holds a patent for a novel class of compounds known as 1-(2-hydroxyaryl)-alkane-1-on-oximes. His patent outlines a procedure for the preparation and use of these compounds, which are characterized by their desirable pharmacological properties. The compounds are particularly valuable for their applications in treating various medical conditions, including asthma, allergic diseases, inflammatory disorders, and thrombosis.
Career Highlights
Joerg Beger is affiliated with Humboldt-Universität zu Berlin, where he has been involved in groundbreaking research. His work focuses on developing compounds with anti-asthmatic, anti-anaphylactic, antiphlogistic, antihypertensive, spasmolytic, antirheumatic, and antithrombotic potentials. This research aims to enhance therapeutic options in both human and veterinary medicine.
Collaborations
Throughout his career, Beger has collaborated with esteemed colleagues, including Juergen Slapke and Tankred Schewe. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Joerg Beger is a prominent figure in pharmaceutical innovation, with a focus on developing compounds that offer significant therapeutic benefits. His contributions to the field are marked by his patent and collaborative efforts, which continue to influence medical research and applications.